8 min read Oral GLP-1s for Weight Loss Maintenance: A New Frontier A groundbreaking study reveals that switching to an oral GLP-1 medication like orforglipron can help individuals maintain a significant portion of their weight loss achieved with injectable therapies, offering a new avenue for long-term obesity management
In a large study of over 18,000 patients, those taking tirzepatide lost about 15.3 percent of body weight in one year compared to 8.3 percent with semaglutide
The combination does not create a hormonal risk beyond what ashwagandha alone produces, but testosterone and DHEA-S should be part of the monitoring panel described above
Realistic Expectations and Consistency It is important to remember that hair growth is a slow process
However, despite being the largest study in this field to date, covering more than 3.5 million pregnancies, relatively few women used these drugs, and some estimates were imprecise